Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Furosemide Stress Test (FST for AKI Progression) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Furosemide Stress Test (FST for AKI Progression)?
The Furosemide Stress Test (FST for AKI Progression) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in nephrology practice. Implements the Chawla Furosemide Stress Test (FST) protocol (1.0–1.5 mg/kg IV furosemide challenge in euvolemic patients with early AKI) using the 200 mL 2-hour urine threshold to stratify risk of dialysis and guide early nephrology consultation. Clinical scoring tools like Furosemide Stress Test (FST for AKI Progression) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Provides a reliable functional dynamic assessment of renal reserve, identifying critically ill patients who will fail conservative management and require early dialytic intervention.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Furosemide Stress Test (FST for AKI Progression):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 199 | Non-Responder (< 200 mL / High Risk of Stage 3 AKI & RRT) | red |
| ≥ 200 | FST Responder (≥ 200 mL / Preserved Tubular Function / Low Dialysis Risk) | green |
When to Exercise Caution
Contraindicated in anuria, pre-existing Stage 5 CKD (baseline eGFR < 15), renal allograft, or acute volume depletion.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •Chawla LS, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17(5):R207.
- •Koyner JL, et al. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. J Am Soc Nephrol. 2015;26(8):2023-2031.
Related Nephrology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Nephrology:
Creatinine Clearance (Cockcroft-Gault)
Estimates renal function for drug dosing using the Cockcroft-Gault equation.
eGFR (CKD-EPI 2021)
Estimates glomerular filtration rate using the 2021 race-free equation.
SOFA Score
Sequential Organ Failure Assessment score for predicting ICU mortality.
Parkland Formula for Burns
Calculates fluid resuscitation requirements for burn patients.
Fractional Excretion of Sodium (FeNa)
Differentiates prerenal disease from acute tubular necrosis (ATN).
Oxygenation Index (OI)
Assesses the severity of hypoxic respiratory failure.